408 related articles for article (PubMed ID: 19589029)
1. Cervical cancer therapy: current, future and anti-angiogensis targeted treatment.
Willmott LJ; Monk BJ
Expert Rev Anticancer Ther; 2009 Jul; 9(7):895-903. PubMed ID: 19589029
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis agents in metastatic or recurrent cervical cancer.
Monk BJ; Willmott LJ; Sumner DA
Gynecol Oncol; 2010 Feb; 116(2):181-6. PubMed ID: 19861227
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for recurrent and metastatic cervical cancer.
Tao X; Hu W; Ramirez PT; Kavanagh JJ
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapies in breast cancer.
Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
[TBL] [Abstract][Full Text] [Related]
5. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
Tewari KS; Monk BJ
Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
[TBL] [Abstract][Full Text] [Related]
6. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
Roukos DH; Tzakos A; Zografos G
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
[No Abstract] [Full Text] [Related]
7. Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies.
Markman M
Trends Pharmacol Sci; 2008 Oct; 29(10):515-9. PubMed ID: 18760845
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis as a strategic target for prostate cancer therapy.
Li Y; Cozzi PJ
Med Res Rev; 2010 Jan; 30(1):23-66. PubMed ID: 19536866
[TBL] [Abstract][Full Text] [Related]
9. Management of early and locally advanced cervical cancer.
Barbera L; Thomas G
Semin Oncol; 2009 Apr; 36(2):155-69. PubMed ID: 19332250
[TBL] [Abstract][Full Text] [Related]
10. The future of targeted therapies in ovarian cancer.
Banerjee S; Gore M
Oncologist; 2009 Jul; 14(7):706-16. PubMed ID: 19592450
[TBL] [Abstract][Full Text] [Related]
11. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of metastatic or recurrent cancer of the cervix].
de la Motte Rouge T; Pautier P; Hamy AS; Duvillard P; Bruna A; Castaigne D; Morice P; Haie-Meder C; Lhommé C
Bull Cancer; 2006 Mar; 93(3):263-70. PubMed ID: 16567313
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of cervical cancer.
Legge F; Fuoco G; Lorusso D; Lucidi A; Borriello M; Pisconti S; Scambia G; Ferrandina G
Expert Opin Pharmacother; 2010 Aug; 11(12):2059-75. PubMed ID: 20642372
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis in melanoma.
Marneros AG
Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
[TBL] [Abstract][Full Text] [Related]
15. Novel strategy of anti-angiogenic therapy for uterine cervical carcinomas.
Fujimoto J
Anticancer Res; 2009 Jul; 29(7):2665-9. PubMed ID: 19596943
[TBL] [Abstract][Full Text] [Related]
16. Management of recurrent cervical cancer: the place of ultra-radical surgery.
Rogo KO; Stendahl U
East Afr Med J; 1993 Jun; 70(6):380-5. PubMed ID: 8261961
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic drugs in ovarian cancer.
Markman M
Expert Opin Pharmacother; 2009 Oct; 10(14):2269-77. PubMed ID: 19671017
[TBL] [Abstract][Full Text] [Related]
18. Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.
Lalami Y; Awada A
Curr Opin Oncol; 2011 May; 23(3):235-40. PubMed ID: 21330922
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for recurrent cervical cancer.
Cadron I; Van Gorp T; Amant F; Leunen K; Neven P; Vergote I
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S113-8. PubMed ID: 17804044
[TBL] [Abstract][Full Text] [Related]
20. Novel chemotherapy approaches for cervical cancer.
Movva S; Rodriguez L; Arias-Pulido H; Verschraegen C
Cancer; 2009 Jul; 115(14):3166-80. PubMed ID: 19452541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]